Citadel Advisors’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,378
Closed -$20.6K 12820
2025
Q2
$20.6K Buy
+11,378
New +$18.8K ﹤0.01% 12097
2024
Q2
Sell
-2,540
Closed -$85K 14303
2024
Q1
$115K Buy
2,540
+2,207
+663% +$105K ﹤0.01% 11167
2023
Q4
$15.7K Sell
333
-561
-63% -$31.2K ﹤0.01% 12821
2023
Q3
$36.2K Sell
894
-14
-2% -$1.42K ﹤0.01% 12123
2023
Q2
$96.8K Sell
908
-4,369
-83% -$1.45M ﹤0.01% 10994
2023
Q1
$1.58M Buy
5,277
+2,364
+81% +$1.01M ﹤0.01% 5821
2022
Q4
$1M Sell
2,913
-655
-18% -$158K ﹤0.01% 6815
2022
Q3
$675K Buy
3,568
+821
+30% +$191K ﹤0.01% 7814
2022
Q2
$581K Sell
2,747
-235
-8% -$49.4K ﹤0.01% 8302
2022
Q1
$997K Sell
2,982
-7
-0.2% -$2.03K ﹤0.01% 7697
2021
Q4
$972K Buy
2,989
+920
+44% +$395K ﹤0.01% 8038
2021
Q3
$1M Sell
2,069
-2,910
-58% -$1.28M ﹤0.01% 8138
2021
Q2
$2.31M Buy
4,979
+555
+13% +$303K ﹤0.01% 6227
2021
Q1
$3.06M Sell
4,424
-46,466
-91% -$37.4M ﹤0.01% 5397
2020
Q4
$37.6M Buy
50,890
+4,039
+9% +$3.15M 0.01% 1196
2020
Q3
$32.5M Buy
46,851
+27,228
+139% +$20.4M 0.01% 1159
2020
Q2
$16.6M Buy
+19,623
New +$12.8M 0.01% 1673

Other funds holding BTAI